RIGGS RORY B

Average Profitability
11.52%
Insider Buys Quantity
2
Insider Buys Sum
$1.03M
Insider Sells Quantity
9
Insider Sells Sum
$13.81M

Insider Activity of RIGGS RORY B

According to the SEC Form 4 filings, RIGGS RORY B, being in a position of

  1. director at Intra-Cellular Therapies, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 4462 shares for $337,193,
    over all time since 2014-02-05, has bought 59144 shares for $1.03M, and sold 25148 shares for $1.55M.

The largest purchase of all time was on 2014-02-05 and amounted to 57142 shares of Intra-Cellular Therapies, Inc. for $999,985.

The largest sale of all time was on 2017-09-13 and amounted to 50000 shares of FibroGen, Inc. for $2.6M.

Biography of RIGGS RORY B

No biography is available at this moment.

2024-06-24SaleIntra-Cellular Therapies, Inc.
ITCI
director
4,462
0.0042%
$75.57$337,193-0.33%
2022-03-16SaleIntra-Cellular Therapies, Inc.
ITCI
20,686
0.022%
$58.72$1.21M-13.33%
2018-03-13SaleFibroGen, Inc.
FGEN
director
24,804
0.0303%
$54.16$1.34M+0.13%
2018-03-12SaleFibroGen, Inc.
FGEN
director
39,386
0.0477%
$54.98$2.17M-2.37%
2018-03-09SaleFibroGen, Inc.
FGEN
director
45,810
0.0556%
$55.75$2.55M-3.53%
2017-12-29PurchaseIntra-Cellular Therapies, Inc.
ITCI
director
2,002
0.0043%
$14.48$28,989+35.53%
2017-09-13SaleFibroGen, Inc.
FGEN
director
50,000
0.0663%
$51.92$2.6M+4.51%
2016-12-16SaleFibroGen, Inc.
FGEN
director
40,000
0.065%
$20.87$834,620+47.43%
2015-09-14SaleFibroGen, Inc.
FGEN
director
51,142
0.0827%
$27.56$1.41M-30.57%
2015-09-11SaleFibroGen, Inc.
FGEN
director
48,858
0.0803%
$27.67$1.35M-29.68%
2014-02-05PurchaseIntra-Cellular Therapies, Inc.
ITCI
director
57,142
0.2046%
$17.50$999,985-12.49%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.